Karyopharm Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Karyopharm Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Karyopharm Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Karyopharm Therapeutics by Rhumbline Advisers
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $119k | 138k | 0.86 |
2023-09-30 | $185k | 138k | 1.34 |
2023-06-30 | $241k | 135k | 1.79 |
2023-03-31 | $406k | 104k | 3.89 |
2022-12-31 | $336k | 99k | 3.40 |
2022-09-30 | $545k | 100k | 5.46 |
2022-06-30 | $412k | 91k | 4.51 |
2022-03-31 | $583k | 79k | 7.37 |
2021-12-31 | $609k | 95k | 6.43 |
2021-09-30 | $560k | 96k | 5.82 |
2021-06-30 | $1.3M | 126k | 10.32 |
2021-03-31 | $1.3M | 121k | 10.52 |
2020-12-31 | $1.9M | 125k | 15.48 |
2020-09-30 | $1.8M | 122k | 14.60 |
2020-06-30 | $2.7M | 140k | 18.94 |
2020-03-31 | $2.4M | 126k | 19.21 |
2019-12-31 | $2.4M | 124k | 19.17 |
2019-09-30 | $1.1M | 116k | 9.62 |
2019-06-30 | $692k | 116k | 5.99 |
2019-03-31 | $774k | 133k | 5.84 |
2018-12-31 | $879k | 94k | 9.37 |
2018-09-30 | $726k | 43k | 17.02 |
2018-06-30 | $770k | 45k | 16.99 |
2018-03-31 | $450k | 34k | 13.41 |
2017-12-31 | $313k | 33k | 9.61 |
2017-09-30 | $826k | 75k | 10.98 |
2017-06-30 | $677k | 75k | 9.05 |
2017-03-31 | $883k | 69k | 12.84 |
2016-12-31 | $609k | 65k | 9.40 |
2016-09-30 | $794k | 82k | 9.73 |
2016-06-30 | $433k | 65k | 6.72 |
2016-03-31 | $199k | 22k | 8.91 |
2015-12-31 | $295k | 22k | 13.26 |
2015-09-30 | $218k | 21k | 10.51 |
2015-06-30 | $531k | 20k | 27.20 |
2015-03-31 | $411k | 13k | 30.58 |
2014-12-31 | $395k | 11k | 37.39 |
2014-09-30 | $358k | 10k | 34.96 |
2014-06-30 | $490k | 11k | 46.58 |